Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Sep 26;103(7):684-6.
doi: 10.1161/CIRCRESAHA.108.185116.

Biological surgery: synergetic angiogenic therapy using coadministration of two progenitor cell populations

Wei Li, Roy L Silverstein
Editorial

Biological surgery: synergetic angiogenic therapy using coadministration of two progenitor cell populations

Wei Li et al. Circ Res. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: None

Figures

Figure 1
Figure 1
Neovascularization is a complex multi-step process requiring precise coordination of multiple cell types responding to many growth factors, cytokines, chemokines, enzymes and mechanical forces. VEGF, vascular endothelial growth factor; VEGF-R, VEGF receptor; Ang, angiopoietin; IGF-1, insulin-like growth factor-1; FGF, fibroblast growth factor; TP; thymidine phosphorylase; MMP, matrix metalloproteinase; uPA, urokinase plasminogen activator; TGF-β, transforming growth factor-β; HIF-1, hypoxia-inducible factor-1; TNFα, tumor necrosis factor α; MCP-1, monocyte chemoattractant protein-1; VCAM-1, vascular cell adhesion molecule-1; PDGF, platelet-derived growth factor; SDF-1, stromal cell-derived factor-1; GM-CSF, Granulocyte macrophage-colony stimulating factor and EPC, endothelial progenitor cell.
See this image and copyright information in PMC

Comment on

References

    1. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999–1007. - PubMed
    1. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408:92–96. - PubMed
    1. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403–409. - PubMed
    1. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 2001;7:738–741. - PubMed
    1. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858–864. - PubMed